News Conference News TVT 2019 Transcarotid Bests Aortic/Apical for Alternative TAVR Access: TVT Registry Shelley Wood June 17, 2019
News Conference News TVT 2019 Vast Numbers of Severe Symptomatic AS Patients Untreated? A Plea and Some Pushback Shelley Wood June 14, 2019
Presentation TVT 2019 Ferumoxytol Enhanced MRA for Transcatheter Aortic Valve Replacement Planning in Patients With Chronic Kidney Disease Presenter: Anjali Sharma June 14, 2019
Presentation TVT 2019 TAVR Safety in Cancer Including in Metastatic Disease: Propensity Score and Machine Learning Supported Multicenter Case-Control Study of Over 6 Million Hospitalizations Presenter: Tariq Thannoun June 14, 2019
Presentation TVT 2019 Future Pillars of Imaging for Structural Heart Disease: 3D Printing and Virtual Reality Presenter: Dmitry Levin June 14, 2019
News Conference News TVT 2019 Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate Shelley Wood June 13, 2019
Presentation TVT 2019 Do We Need a Randomized Trial in Bicuspid Aortic Valve Disease? Presenter: Vinod Thourani June 13, 2019
News Conference News TVT 2019 PCI During or After TAVR No Riskier Than PCI Before Valve Replacement Michael O'Riordan June 13, 2019
Presentation TVT 2019 3 Illustrative Cases (Optimal Valve Sizing, Reducing New Pacemakers, and Calcified Bicuspid Disease) – A Case-Based Discussion Presenter: Christopher Meduri June 13, 2019
Presentation TVT 2019 Surgery After Failed TAVR: What Does Redo Surgery Look Like in 10 Years? A New Iatrogenic Disease Presenter: Vinayak Bapat June 13, 2019
Presentation TVT 2019 Outcomes of Transcatheter Aortic Valve Replacement (TAVR) for Mixed Aortic Valve Disease: Results From the TVT Registry Presenter: Bhaskar Bhardwaj June 13, 2019
Presentation TVT 2019 Are There Opportunities in Your Valve Program? Presenter: Sarah Clarke June 12, 2019
Presentation TVT 2019 Low-Risk Approval: Who Isn’t a Candidate for TAVR? Presenter: Tsuyoshi Kaneko June 12, 2019
News Conference News TVT 2017 Valve Leaflet Thrombosis: Treat It or Leave It Be? Shelley Wood June 19, 2017
News Conference News TVT 2017 Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base Michael O'Riordan June 17, 2017
News Conference News TVT 2017 Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial Shelley Wood June 16, 2017
News Conference News TVT 2017 Volume Underload? More TAVRs Done, the Better the Operator Outcomes, Yet Many Patients Go Untreated Michael O'Riordan June 16, 2017